|
82
|
269
|
4yc8A |
C-helix-out binding of dasatinib analog to c-abl kinase |
|
85
|
270
|
4yjqA |
Syk kinase domain in complex with inhibitor gtc000224 |
|
87
|
270
|
4yjrA |
Syk kinase domain in complex with inhibitor gtc000225 |
|
90
|
266
|
4y95A |
Crystal structure of the kinase domain of bruton's tyrosine kinase with mutations in the activation loop |
|
90
|
318
|
4y85A |
Crystal structure of cot kinase domain in complex with 5-(5-(1h-indol-3-yl)-1h-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine |
|
90
|
270
|
4yjoA |
The kinase domain of human spleen tyrosine (syk) in complex with gtc000222 |
|
98
|
362
|
5ci6A |
Crystal structure of arabidopsis thaliana mpk6 |
|
100
|
356
|
4y5hA |
Pyridopyrimidinone derivatives as potent and selective c-jun n-terminal kinase (jnk) inhibitors |
|
93
|
316
|
5cnnA |
Crystal structure of the egfr kinase domain mutant i682q |
|
76
|
275
|
4ybjA |
Type ii dasatinib analog crystallized with c-src kinase |
|
163
|
472
|
4y5qA |
Activated calcium-dependent protein kinase 1 from cryptosporidium parvum (cpcdpk1) in complex with amp |
|
78
|
292
|
4y72A |
Human cdk1/cyclinb1/cks2 with inhibitor |
|
113
|
345
|
4xrlA |
Crystal structure at room temperature of erk2 in complex with an inhibitor |
|
111
|
347
|
4xp3A |
Crystal structure of erk2 in complex with an inhibitor |
|
80
|
273
|
4xh6A |
Crystal structure of proto-oncogene kinase pim1 bound to hispidulin |
|
90
|
274
|
4xg6A |
Crystal structure of an inhibitor-bound syk |
|
87
|
291
|
4xcuA |
Crystal structure of fgfr4 with an irreversible inhibitor |
|
65
|
270
|
4xv3A |
B-raf kinase v600e oncogenic mutant in complex with plx7922 |
|
104
|
349
|
4xj0A |
Crystal structure of erk2 in complex with an inhibitor 14k |
|
85
|
273
|
4xg2A |
Crystal structure of ligand-free syk |
|
93
|
295
|
4xyfA |
Crystal structure of c-met in complex with (s)-5-(8-fluoro-3-(1-(3-(2-methoxyethoxy)quinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole |
|
76
|
272
|
4xv2A |
B-raf kinase v600e oncogenic mutant in complex with dabrafenib |
|
111
|
347
|
4xp0A |
Crystal structure of erk2 in complex with an inhibitor |
|
94
|
310
|
4xlvA |
Crystal structure of the activated insulin receptor tyrosine kinase dimer |
|
109
|
346
|
4xrjA |
Crystal structure of erk2 in complex with an inhibitor |
|
84
|
275
|
4xv9A |
B-raf kinase domain in complex with plx5568 |
|
102
|
345
|
4xoyA |
Crystal structure of erk2 in complex with an inhibitor |
|
83
|
270
|
4xg9A |
Crystal structure of an inhibitor-bound syk |
|
84
|
272
|
4xg3A |
Crystal structure of an inhibitor-bound syk |
|
86
|
289
|
4xx9A |
Crystal structure of pdk1 in complex with atp and the pif-pocket ligand rf4 |
|
114
|
347
|
4xozA |
Crystal structure of erk2 in complex with an inhibitor |
|
82
|
274
|
4xhkB |
Pim1 kinase in complex with compound 1s |
|
80
|
270
|
4xg8A |
Crystal structure of an inhibitor-bound syk |
|
73
|
297
|
4xufA |
Crystal structure of the flt3 kinase domain bound to the inhibitor quizartinib (ac220) |
|
86
|
273
|
4xg4A |
Crystal structure of an inhibitor-bound syk |
|
71
|
268
|
4xv1A |
B-raf kinase v600e oncogenic mutant in complex with plx7904 |
|
92
|
297
|
4xs2A |
Irak4-inhibitor co-structure |
|
107
|
346
|
4xneA |
Crystal structure of erk2 in complex with an inhibitor |
|
84
|
273
|
4xeyA |
Crystal structure of an sh2-kinase domain construct of c-abl tyrosine kinase |
|
105
|
297
|
4y73A |
Crystal structure of irak4 kinase domain with inhibitor |
|
86
|
273
|
4xg7A |
Crystal structure of an inhibitor-bound syk |
|
93
|
293
|
4xbuA |
In vitro crystal structure of pak4 in complex with inka peptide |
|
92
|
295
|
4xmoA |
Crystal structure of c-met in complex with (r)-5-(8-fluoro-3-(1-fluoro-1-(3-methoxyquinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole |
|
100
|
343
|
4xbrA |
In cellulo crystal structure of pak4 in complex with inka |
|
99
|
356
|
4y46A |
Pyridopyrimidinone derivatives as potent and selective c-jun n-terminal kinase (jnk) inhibitors |
|
108
|
346
|
4xp2A |
Crystal structure of erk2 in complex with an inhibitor |
|
79
|
268
|
4xliA |
Crystal structure of abl2/arg kinase in complex with dasatinib |
|
169
|
465
|
4wg3A |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1610 |
|
108
|
356
|
4whzA |
Design and synthesis of highly potent and isoform selective jnk3 inhibitors: sar studies on aminopyrazole derivatives |
|
95
|
313
|
4uy9A |
Structure of mlk1 kinase domain with leucine zipper 1 |
